Article Figures & Data
Figures
- Fig. 1
The timeline for the typical drug discovery process, which can be accelerated by including serendipity drug discovery and repurposing of existing drugs or drug candidates (framed).
- Fig. 2
Comparison of drug development strategies that target various testicular and post-testicular cell types. HPT, hypothalamus-pituitary-testis; N/A, not applicable.
Additional Files
Data Supplement
- Supplemental Tables -
Supplemental Table S1. Percentage of men who will take up a male contraceptive method.
Supplemental Table S2. The landscape of male contraceptive development.
- Supplemental Tables -
In this issue
Jump to section
- Article
- Abstract
- I. Male Contraceptive Development Is, After All, a Women’s Health Issue
- II. How Do Women and Men View a Potential Male Contraceptive?
- III. What Is the Market Size for Male Contraceptives?
- IV. Why the Long Delay with Male Contraceptives?
- V. Why Is Serendipity Observation Important in Drug Discovery?
- VI. Why Is Depleting Sperm or Spermatogenic Cells for Male Contraception Problematic?
- VII. Novel Methods Currently in Development
- VIII. Perspectives
- Acknowledgments
- Data Availability
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
- PDF + SI
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement